OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Neuroimmune Alterations in Autism: A Translational Analysis Focusing on the Animal Model of Autism Induced by Prenatal Exposure to Valproic Acid
Iohanna Deckmann, Gustavo Brum Schwingel, Mellanie Fontes‐Dutra, et al.
NeuroImmunoModulation (2018) Vol. 25, Iss. 5-6, pp. 285-299
Open Access | Times Cited: 58

Showing 1-25 of 58 citing articles:

Prenatal valproate in rodents as a tool to understand the neural underpinnings of social dysfunctions in autism spectrum disorder
Anna Maria Tartaglione, Sara Schiavi, Gemma Calamandrei, et al.
Neuropharmacology (2019) Vol. 159, pp. 107477-107477
Closed Access | Times Cited: 93

Cannabidivarin Treatment Ameliorates Autism-Like Behaviors and Restores Hippocampal Endocannabinoid System and Glia Alterations Induced by Prenatal Valproic Acid Exposure in Rats
Erica Zamberletti, Marina Gabaglio, Marie Woolley-Roberts, et al.
Frontiers in Cellular Neuroscience (2019) Vol. 13
Open Access | Times Cited: 82

Role of Neuroinflammation in Autism Spectrum Disorder and the Emergence of Brain Histaminergic System. Lessons Also for BPSD?
Nermin Eissa, Adel Sadeq, Astrid Sasse, et al.
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 75

Emerging mechanisms of valproic acid-induced neurotoxic events in autism and its implications for pharmacological treatment
Abdoh Taleb, Wen Lin, Xiang Xu, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 137, pp. 111322-111322
Open Access | Times Cited: 65

Microglia and Astroglia—The Potential Role in Neuroinflammation Induced by Pre- and Neonatal Exposure to Lead (Pb)
Magdalena Gąssowska-Dobrowolska, Mikołaj Chlubek, Agnieszka Kolasa, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 12, pp. 9903-9903
Open Access | Times Cited: 26

The dual-active histamine H3 receptor antagonist and acetylcholine esterase inhibitor E100 ameliorates stereotyped repetitive behavior and neuroinflammmation in sodium valproate induced autism in mice
Nermin Eissa, Sheikh Azimullah, Petrilla Jayaprakash, et al.
Chemico-Biological Interactions (2019) Vol. 312, pp. 108775-108775
Closed Access | Times Cited: 55

Chronic acetyl-L-carnitine treatment alleviates behavioral deficits and neuroinflammation through enhancing microbiota derived-SCFA in valproate model of autism
Elham Zahedi, Seyed-Shahabeddin Sadr, Ashkan Sanaeierad, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 163, pp. 114848-114848
Open Access | Times Cited: 18

Beneficial effects of pioglitazone, a selective peroxisome proliferator‐activated receptor‐γ agonist in prenatal valproic acid‐induced behavioral and biochemical autistic like features in Wistar rats
Roohi Mirza, Bhupesh Sharma
International Journal of Developmental Neuroscience (2019) Vol. 76, Iss. 1, pp. 6-16
Closed Access | Times Cited: 49

Prenatal Exposure to Valproic Acid Affects Microglia and Synaptic Ultrastructure in a Brain-Region-Specific Manner in Young-Adult Male Rats: Relevance to Autism Spectrum Disorders
Magdalena Gąssowska-Dobrowolska, Magdalena Cieślik, Grzegorz A. Czapski, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 10, pp. 3576-3576
Open Access | Times Cited: 48

Role of the Gut Microbiota in the Pathophysiology of Autism Spectrum Disorder: Clinical and Preclinical Evidence
Léa Roussin, Naika Prince, Paula Perez‐Pardo, et al.
Microorganisms (2020) Vol. 8, Iss. 9, pp. 1369-1369
Open Access | Times Cited: 45

Gut microbiota and neuropsychiatric disorders: Implications for neuroendocrine-immune regulation
Tongtong Ge, Xiaoxiao Yao, Haisheng Zhao, et al.
Pharmacological Research (2021) Vol. 173, pp. 105909-105909
Closed Access | Times Cited: 34

Valproic Acid and Propionic Acid Modulated Mechanical Pathways Associated with Autism Spectrum Disorder at Prenatal and Neonatal Exposure
Amit Raj Sharma, Gitika Batra, Lokesh Saini, et al.
CNS & Neurological Disorders - Drug Targets (2021) Vol. 21, Iss. 5, pp. 399-408
Closed Access | Times Cited: 33

Novel probiotic treatment of autism spectrum disorder associated social behavioral symptoms in two rodent models
Kitti Mintál, Attila Tóth, Edina Hormay, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 24

Alterations in Tau Protein Level and Phosphorylation State in the Brain of the Autistic-Like Rats Induced by Prenatal Exposure to Valproic Acid
Magdalena Gąssowska-Dobrowolska, Agnieszka Kolasa, Magdalena Cieślik, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 6, pp. 3209-3209
Open Access | Times Cited: 31

The histamine H3R and dopamine D2R/D3R antagonist ST-713 ameliorates autism-like behavioral features in BTBR T+tf/J mice by multiple actions
Karthikkumar Venkatachalam, Nermin Eissa, M. Awad, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 138, pp. 111517-111517
Open Access | Times Cited: 24

Valproate-induced murine autism spectrum disorder is associated with dysfunction of amygdala parvalbumin interneurons and downregulation of AMPK/SIRT1/PGC1α signaling
Elham Zahedi, Seyed Shahabeddin Sadr, Ashkan Sanaeierad, et al.
Metabolic Brain Disease (2023) Vol. 38, Iss. 6, pp. 2093-2103
Closed Access | Times Cited: 9

Advances in the Treatment of Autism Spectrum Disorder: Current and Promising Strategies
Konstantin Yenkoyan, Zadik Ounanian, Margarita Mirumyan, et al.
Current Medicinal Chemistry (2023) Vol. 31, Iss. 12, pp. 1485-1511
Open Access | Times Cited: 9

Immunological Biomarkers in Autism Spectrum Disorder: The Role of TNF-Alpha and Dependent Trends in Serum IL-6 and CXCL8
Cătălina Mihaela Anastasescu, Veronica Gheorman, E C Stoicănescu, et al.
Life (2024) Vol. 14, Iss. 9, pp. 1201-1201
Open Access | Times Cited: 3

Endogenous Retroviruses Activity as a Molecular Signature of Neurodevelopmental Disorders
Emanuela Balestrieri, Claudia Matteucci, Chiara Cipriani, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 23, pp. 6050-6050
Open Access | Times Cited: 26

Polymorphism of interleukin-1β and interleukin-1 receptor antagonist genes in children with autism spectrum disorders
Khaled Saad, Alameldin M. Abdallah, Ahmed A. Abdelrahman, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2020) Vol. 103, pp. 109999-109999
Closed Access | Times Cited: 25

Resveratrol prevents brain edema, blood–brain barrier permeability, and altered aquaporin profile in autism animal model
Iohanna Deckmann, Júlio Santos‐Terra, Mellanie Fontes‐Dutra, et al.
International Journal of Developmental Neuroscience (2021) Vol. 81, Iss. 7, pp. 579-604
Open Access | Times Cited: 22

Transcription factors in neurodevelopmental and associated psychiatric disorders: A potential convergence for genetic and environmental risk factors
Júlio Santos‐Terra, Iohanna Deckmann, Mellanie Fontes‐Dutra, et al.
International Journal of Developmental Neuroscience (2021) Vol. 81, Iss. 7, pp. 545-578
Open Access | Times Cited: 18

Behavioral and Biochemical Assays for Autism Models of Wistar Rats
Kavitha Ukkirapandian, Kayalvizhi Elumalai, Karthika Priyadharshini Udaykumar, et al.
Cureus (2024)
Open Access | Times Cited: 2

The neuroprotective effect of Diosgenin in the rat Valproic acid model of autism
Mohammad Reza naghdi, Reza Ahadi, Ali Motamed Nezhad, et al.
Brain Research (2024) Vol. 1838, pp. 148963-148963
Closed Access | Times Cited: 2

Page 1 - Next Page

Scroll to top